Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer

Objective: Gynecologic cancers are associated with a high risk of venous thromboembolism (VTE). The Khorana score is a validated tool to assess risk of VTE in cancer patients. The purpose of this study is to determine if the Khorana score can be used as a risk stratification tool for VTE in patients...

Descrición completa

Detalles Bibliográficos

Principais autores:	Rachael N. Piver, Vincent M. Wagner, Monica D. Levine, Floor J. Backes, Laura J. Chambers, David E. Cohn, Larry J. Copeland, Casey M. Cosgrove, Christa I. Nagel, David M. O'Malley, Kristin L. Bixel
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2023-04-01
Series:	Gynecologic Oncology Reports
Assuntos:	Chemotherapy Endometrial cancer Khorana score Thromboprophylaxis Uterine cancer Venous thromboembolism
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2352578923000255
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!